Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple plasma constituents refers to the collective group of organic and inorganic substances found in the liquid matrix of blood, including proteins, electrolytes, hormones, and nutrients (StatPearls, Physiology, Plasma Protein). This term is frequently utilized in pharmacological contexts to describe treatments that do not target a single receptor or enzyme but instead affect the overall composition or volume of the plasma. Major components include albumin, which is responsible for maintaining colloid osmotic pressure, and various globulins and clotting factors that facilitate immunity and hemostasis (Merck Manual, Plasma Derivatives). Therapeutic interventions involving these constituents, such as plasma expanders or transfusion of fresh frozen plasma, are primarily used to manage conditions like hypovolemic shock, severe burns, and coagulation disorders (PubMed, PMID: 28613500). Because the term encompasses a heterogeneous mixture of molecules, it is classified as a non-specific target or a physiological compartment rather than a distinct molecular entity. It serves as a vital medium for the transport of drugs, metabolites, and gases throughout the body, influencing the pharmacokinetics of many systemic medications (Wikipedia, Blood plasma). Monitoring these constituents is essential in clinical settings to ensure homeostasis and prevent complications such as edema or electrolyte toxicity.
Restoration of intravascular volume, replacement of essential proteins or clotting factors, and maintenance of osmotic and electrolyte balance.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple plasma constituents.